{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:22:11Z","timestamp":1785424931761,"version":"3.56.0"},"reference-count":73,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Silesia"},{"id":[{"id":"https:\/\/ror.org\/005k7hp45","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background\/Objectives: Metformin has been proposed as a potential treatment for hyperprolactinemia irrespective of etiology. Previous studies suggest that vitamin D deficiency attenuates the prolactin-lowering effect of metformin in women. This study examined whether vitamin D status modifies the effects of this agent on prolactin and other anterior pituitary hormones in men with iatrogenic hyperprolactinemia. Methods: Seventy-five adult men with antipsychotic-induced hyperprolactinemia and type 2 diabetes or prediabetes were enrolled. Participants were assigned to three equal groups based on vitamin D status and supplementation: vitamin D-naive men with sufficient levels (group 1), vitamin D-naive men with deficiency (group 2), and men with sufficient vitamin D levels receiving oral supplementation for at least six months (group 3). All participants received metformin (3 g\/day) for six months. Plasma 25-hydroxyvitamin D, markers of glucose metabolism, total and monomeric prolactin, TSH, gonadotropins, ACTH, testosterone, and IGF-1 were measured at baseline and after treatment. Results: Baseline characteristics were comparable among groups except for 25-hydroxyvitamin D levels. Seventy participants completed the study. Metformin improved glycemic control and insulin sensitivity in all groups, with greater effects in men with sufficient vitamin D status. Reductions in total and monomeric prolactin were observed only in groups 1 and 3 and were associated with baseline prolactin concentrations and pretreatment 25-hydroxyvitamin D levels. These changes were accompanied by modest increases in LH and testosterone, and improvements in sexual functioning. Vitamin D levels and other hormonal parameters remained unchanged. The magnitude of the metformin effect did not differ between groups 1 and 3. Conclusions: Adequate vitamin D status is necessary for metformin to reduce prolactin levels in men with iatrogenic hyperprolactinemia.<\/jats:p>","DOI":"10.3390\/nu18071062","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:32:47Z","timestamp":1774611167000},"page":"1062","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vitamin D Adequacy Conditions the Prolactin-Suppressive Effect of Metformin in Men Receiving Prolactin-Elevating Medications"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5454-2620","authenticated-orcid":false,"given":"Robert","family":"Krysiak","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9276-4563","authenticated-orcid":false,"given":"Karolina","family":"Kowalcze","sequence":"additional","affiliation":[{"name":"Department of Pediatrics in Bytom, Faculty of Health Sciences in Katowice, Medical University of Silesia, Stefana Batorego 15, 41-902 Bytom, Poland"},{"name":"Department of Pathophysiology, Faculty of Medicine, Academy of Silesia, Rolna 43, 40-555 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8523-6906","authenticated-orcid":false,"given":"Giovanni","family":"Cangelosi","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Experimental Medicine and \u201cStefania Scuri\u201d Public Health Department, University of Camerino, 62032 Camerino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6925-7515","authenticated-orcid":false,"given":"Andrea","family":"Deledda","sequence":"additional","affiliation":[{"name":"Endocrinology and Obesity Unit, Department of Medical Sciences and Public Health, University of Cagliari, 09124 Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-2906","authenticated-orcid":false,"given":"Bogus\u0142aw","family":"Okopie\u0144","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"E143","DOI":"10.1210\/jc.2013-2965","article-title":"Effects of treatment with metformin on TSH levels: A meta-analysis of literature studies","volume":"99","author":"Lupoli","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"18757","DOI":"10.1038\/s41598-023-43266-9","article-title":"The effect of metformin therapy on serum thyrotropin and free thyroxine concentrations in patients with type 2 diabetes: A meta-analysis","volume":"13","author":"Amirabadizadeh","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1055\/a-0584-0006","article-title":"The Effect of Metformin on Serum Gonadotropin Levels in Postmenopausal Women with Diabetes and Prediabetes: A Pilot Study","volume":"126","author":"Krysiak","year":"2018","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/01443610310000100123","article-title":"Medical vs. surgical treatment for clomiphene citrate-resistant women with polycystic ovary syndrome","volume":"23","author":"Malkawi","year":"2003","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1055\/a-1018-9606","article-title":"Treatment with Metformin and Combination of Metformin Plus Pioglitazone on Serum Levels of IL-6 and IL-8 in Polycystic Ovary Syndrome: A Randomized Clinical Trial","volume":"51","author":"Ali","year":"2019","journal-title":"Horm. Metab. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.25122\/jml-2023-0317","article-title":"Effects of combined metformin and cabergoline versus metformin alone on ovarian and hormonal activities in Iraqi patients with PCOS and hyperprolactinemia: A randomized clinical trial","volume":"16","author":"Hamad","year":"2023","journal-title":"J. Med. Life"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s12020-014-0428-2","article-title":"The effect of short-term metformin treatment on plasma prolactin levels in bromocriptine-treated patients with hyperprolactinaemia and impaired glucose tolerance: A pilot study","volume":"49","author":"Krysiak","year":"2015","journal-title":"Endocrine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejim.2016.01.015","article-title":"The effect of metformin on prolactin levels in patients with drug-induced hyperprolactinemia","volume":"30","author":"Krysiak","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.wneu.2018.02.188","article-title":"Combination Treatment with Bromocriptine and Metformin in Patients with Bromocriptine-Resistant Prolactinomas: Pilot Study","volume":"115","author":"Liu","year":"2018","journal-title":"World Neurosurg."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Liu, X., Sun, X., Li, L., Zeng, K., Li, Y., Gao, Y., and Ma, J. (2023). Co-prescription of aripiprazole on prolactin levels in long-term hospitalized chronic schizophrenic patients with co-morbid type 2 diabetes: A retrospective clinical study. Front. Psychiatry, 14.","DOI":"10.3389\/fpsyt.2023.1124691"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1176\/appi.ajp.2012.11091432","article-title":"Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: A double-blind, randomized, placebo-controlled study","volume":"169","author":"Wu","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Zhu, C., Li, R., Ju, M., Xiao, X., Yuan, T.F., Jin, Z., and Zhao, J. (2022). Metformin in the Treatment of Amisulpride-Induced Hyperprolactinemia: A Clinical Trial. Front. Mol. Neurosci., 15.","DOI":"10.3389\/fnmol.2022.892477"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/0269881117699630","article-title":"Adjunctive metformin for antipsychotic-related hyperprolactinemia: A meta-analysis of randomized controlled trials","volume":"31","author":"Zheng","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/cen.15281","article-title":"The Impact of Metformin on Plasma Prolactin Levels in Antipsychotics-Treated Men With Hyperprolactinemia and Early-Onset Androgenic Alopecia","volume":"103","author":"Krysiak","year":"2025","journal-title":"Clin. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1055\/s-0043-122224","article-title":"Sex-Dependent Effect of Metformin on Serum Prolactin Levels In Hyperprolactinemic Patients with Type 2 Diabetes: A Pilot Study","volume":"126","author":"Krysiak","year":"2018","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yfrne.2017.02.003","article-title":"Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics","volume":"45","author":"Montejo","year":"2017","journal-title":"Front. Neuroendocrinol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1871530317666170424102332","article-title":"Hyperprolactinemia Induced by Antipsychotics: From Diagnosis to Treatment Approach","volume":"17","author":"Milano","year":"2017","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3892\/mmr.2025.13479","article-title":"Metabolic syndrome in patients with schizophrenia: Underlying mechanisms and therapeutic approaches (Review)","volume":"31","author":"Manta","year":"2025","journal-title":"Mol. Med. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11892-015-0704-4","article-title":"Diabetes and Schizophrenia","volume":"16","author":"Suvisaari","year":"2016","journal-title":"Curr. Diab Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jad.2021.12.110","article-title":"Prevalence of type 2 diabetes mellitus, impaired fasting glucose, general obesity, and abdominal obesity in patients with bipolar disorder: A systematic review and meta-analysis","volume":"300","author":"Liu","year":"2022","journal-title":"J. Affect. Disord."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2337\/diacare.26.5.1597","article-title":"Patients on atypical antipsychotic drugs: Another high-risk group for type 2 diabetes","volume":"26","author":"Lean","year":"2003","journal-title":"Diabetes Care"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1089\/met.2023.0003","article-title":"Antipsychotic-Induced Metabolic Syndrome: A Review","volume":"21","author":"Akinola","year":"2023","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e100823","DOI":"10.1136\/gpsych-2022-100823","article-title":"A glimpse of gender differences in schizophrenia","volume":"35","author":"Li","year":"2022","journal-title":"Gen. Psychiatr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jad.2024.02.038","article-title":"Sex differences in effectiveness and adverse effects of mood stabilizers and antipsychotics: A systematic review","volume":"352","author":"Ercis","year":"2024","journal-title":"J. Affect. Disord."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"112959","DOI":"10.1016\/j.psychres.2020.112959","article-title":"Vitamin D deficiency and Schizophrenia in Adults: A Systematic Review and Meta-analysis of Observational Studies","volume":"288","author":"Zhu","year":"2020","journal-title":"Psychiatry Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Shahini, N., Jazayeri, S., Jahanshahi, R., and Charkazi, A. (2022). Relationship of serum homocysteine and vitamin D with positive, negative, and extrapyramidal symptoms in schizophrenia: A case-control study in Iran. BMC Psychiatry, 22.","DOI":"10.1186\/s12888-022-04246-x"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zhou, Z., Nagashima, T., Toda, C., Kobayashi, M., Suzuki, T., Nagayasu, K., Shirakawa, H., Asai, S., and Kaneko, S. (2023). Vitamin D supplementation is effective for olanzapine-induced dyslipidemia. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1135516"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/jcpt.13447","article-title":"Vitamin D status determines the impact of metformin on circulating prolactin levels in premenopausal women","volume":"46","author":"Krysiak","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2025). 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025. Diabetes Care, 48, S27\u2013S49.","DOI":"10.2337\/dc25-S002"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_31","unstructured":"World Medical Association (2026, March 18). WMA Statement on Vitamin D Insufficiency. Available online: https:\/\/www.wma.net\/policies-post\/wma-statement-on-vitamin-d-insufficiency\/."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ecl.2010.02.008","article-title":"Low vitamin D status: Definition, prevalence, consequences, and correction","volume":"39","author":"Binkley","year":"2010","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"752","DOI":"10.4065\/mcp.2010.0138","article-title":"Vitamin D deficiency in adults: When to test and how to treat","volume":"85","author":"Kennel","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1159\/000545525","article-title":"The Effect of Metformin on Prolactin Concentration in Women with Hyperprolactinemia and Subclinical Hyperthyroidism","volume":"115","author":"Krysiak","year":"2025","journal-title":"Neuroendocrinology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","article-title":"Prolactin: Structure, function, and regulation of secretion","volume":"80","author":"Freeman","year":"2000","journal-title":"Physiol. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ncpendmet0447","article-title":"Technology insight: Measuring prolactin in clinical samples","volume":"3","author":"Smith","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/ebmed-2017-110884","article-title":"Catalogue of bias: Observer bias","volume":"23","author":"Mahtani","year":"2018","journal-title":"BMJ Evid. Based Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.ijir.3900857","article-title":"The International Index of Erectile Function (IIEF): A state-of-the-science review","volume":"14","author":"Rosen","year":"2002","journal-title":"Int. J. Impot. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/imj.16208","article-title":"The utility of rested prolactin sampling in the evaluation of hyperprolactinaemia","volume":"54","author":"Wilkinson","year":"2024","journal-title":"Intern. Med. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.steroids.2014.05.010","article-title":"Adverse health effects of testosterone deficiency (TD) in men","volume":"88","author":"Traish","year":"2014","journal-title":"Steroids"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/B978-0-444-63247-0.00027-4","article-title":"Psychiatric disorders and sexual dysfunction","volume":"130","author":"Waldinger","year":"2015","journal-title":"Handb. Clin. Neurol."},{"key":"ref_42","first-page":"153","article-title":"Clinical Presentations of Drug-Induced Hyperprolactinaemia: A Literature Review","volume":"37","author":"Junqueira","year":"2023","journal-title":"Pharmaceut Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of metformin","volume":"50","author":"Graham","year":"2011","journal-title":"Clin. Pharmacokinet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00228-018-2593-3","article-title":"Role of metformin in overweight and obese people without diabetes: A systematic review and network meta-analysis","volume":"75","author":"Hui","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"n2103","DOI":"10.1136\/bmj.n2103","article-title":"Use of metformin to prolong gestation in preterm pre-eclampsia: Randomised, double blind, placebo controlled trial","volume":"374","author":"Cluver","year":"2021","journal-title":"BMJ"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1254\/jphs.92.171","article-title":"Macroprolactinemia: A new cause of hyperprolactinemia","volume":"92","author":"Hattori","year":"2003","journal-title":"J. Pharmacol. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1095\/biolreprod.110.087023","article-title":"Metformin decreases GnRH- and activin-induced gonadotropin secretion in rat pituitary cells: Potential involvement of adenosine 5\u2032 monophosphate-activated protein kinase (PRKA)","volume":"84","author":"Tosca","year":"2011","journal-title":"Biol. Reprod."},{"key":"ref_48","first-page":"270","article-title":"Macroprolactinaemia in diabetic patients","volume":"31","author":"Gulcelik","year":"2010","journal-title":"Neuro Endocrinol. Lett."},{"key":"ref_49","first-page":"73","article-title":"Are Shorter Versions of the Positive and Negative Syndrome Scale (PANSS) Doable? A Critical Review","volume":"14","author":"Lindenmayer","year":"2017","journal-title":"Innov. Clin. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1192\/j.eurpsy.2025.10072","article-title":"Schizophrenia treatment preferences of psychiatrists versus guidelines: A European perspective","volume":"68","author":"Nordentoft","year":"2025","journal-title":"Eur. Psychiatry"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Cai, T., Hu, Y., Ding, B., Yan, R., Liu, B., Cai, L., Jing, T., Jiang, L., Xie, X., and Wang, Y. (2021). Effect of Metformin on Testosterone Levels in Male Patients With Type 2 Diabetes Mellitus Treated With Insulin. Front Endocrinol, 12.","DOI":"10.3389\/fendo.2021.813067"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e13816","DOI":"10.1111\/and.13816","article-title":"The effect of metformin treatment on the basal and gonadotropin-stimulated steroidogenesis in male rats with type 2 diabetes mellitus","volume":"52","author":"Derkach","year":"2020","journal-title":"Andrologia"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"105589","DOI":"10.1016\/j.jsbmb.2020.105589","article-title":"Vitamin D and sex steroid production in men with normal or impaired Leydig cell function","volume":"199","author":"Holt","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/MOU.0000000000000442","article-title":"Testosterone therapy improves erectile function and libido in hypogonadal men","volume":"27","author":"Rizk","year":"2017","journal-title":"Curr. Opin. Urol."},{"key":"ref_55","first-page":"S131","article-title":"Psychiatric illness and sexual function","volume":"10","author":"Segraves","year":"1998","journal-title":"Int. J. Impot. Res."},{"key":"ref_56","first-page":"CD003546","article-title":"Management of sexual dysfunction due to antipsychotic drug therapy","volume":"11","author":"Schmidt","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1111\/dom.13327","article-title":"Long-term treatment with metformin in type 2 diabetes and vitamin D levels: A post-hoc analysis of a randomized placebo-controlled trial","volume":"20","author":"Out","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/cap.2017.0104","article-title":"Calcium and Vitamin D Supplementation in Boys with Risperidone-Induced Hyperprolactinemia: A Randomized, Placebo-Controlled Pilot Study","volume":"28","author":"Calarge","year":"2018","journal-title":"J. Child. Adolesc. Psychopharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/s-0029-1211133","article-title":"Lack of stimulating effect on thyrotropic and lactotropic secretion during prolonged calcitriol administration","volume":"99","author":"Zofkova","year":"1992","journal-title":"Exp. Clin. Endocrinol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1139\/cjpp-2020-0435","article-title":"Vitamin D3 potentiates the nephroprotective effects of metformin in a rat model of metabolic syndrome: Role of AMPK\/SIRT1 activation and DPP-4 inhibition","volume":"99","author":"Wahba","year":"2021","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/1440-1681.12409","article-title":"Vitamin D3 potentiates the growth inhibitory effects of metformin in DU145 human prostate cancer cells mediated by AMPK\/mTOR signalling pathway","volume":"42","author":"Li","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Pirchio, R., Graziadio, C., Colao, A., Pivonello, R., and Auriemma, R.S. (2022). Metabolic effects of prolactin. Front Endocrinol, 13.","DOI":"10.3389\/fendo.2022.1015520"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1002\/cne.25100","article-title":"Defining vitamin D receptor expression in the brain using a novel VDR(Cre) mouse","volume":"529","author":"Liu","year":"2021","journal-title":"J. Comp. Neurol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1734-1140(10)70357-1","article-title":"Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide","volume":"62","author":"Labuzek","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/jnc.15829","article-title":"Vitamin D: A potent regulator of dopaminergic neuron differentiation and function","volume":"166","author":"Pertile","year":"2023","journal-title":"J. Neurochem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1677\/joe.1.05844","article-title":"Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome","volume":"184","author":"Cardoza","year":"2005","journal-title":"J. Endocrinol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.4088\/JCP.09m05274yel","article-title":"The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: A meta-analysis","volume":"71","author":"Ehret","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41398-020-0785-y","article-title":"Adjunctive metformin for antipsychotic-induced dyslipidemia: A meta-analysis of randomized, double-blind, placebo-controlled trials","volume":"10","author":"Jiang","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: Guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1176\/appi.ajp.20230922","article-title":"Psychotropic Drug-Related Weight Gain and Its Treatment","volume":"181","author":"McIntyre","year":"2024","journal-title":"Am. J. Psychiatry"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/070674370104600111","article-title":"Regression toward the mean: Its etiology, diagnosis, and treatment","volume":"46","author":"Streiner","year":"2001","journal-title":"Can. J. Psychiatry"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1373\/clinchem.2005.065854","article-title":"Specificity and clinical utility of methods for the detection of macroprolactin","volume":"52","author":"Kavanagh","year":"2006","journal-title":"Clin. Chem."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/7\/1062\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:55:35Z","timestamp":1775058935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/7\/1062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":73,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["nu18071062"],"URL":"https:\/\/doi.org\/10.3390\/nu18071062","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]}}}